These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic potential of beta-receptor blockers in acute anterior wall infarct]. Jentsch G MMW Munch Med Wochenschr; 1982 Jun; 124(22):543-4. PubMed ID: 6124886 [No Abstract] [Full Text] [Related]
4. [Role of beta-blockers in the pharmacologic treatment of congestive heart failure]. Longo A Rev Port Cardiol; 1989; 8(7-8):563-8. PubMed ID: 2576636 [TBL] [Abstract][Full Text] [Related]
5. [Factors regulating exercise capacity in heart failure and effects of Beta- receptor blockers on exercise tolerance]. Birand A Anadolu Kardiyol Derg; 2003 Dec; 3(4):319-22. PubMed ID: 14675881 [No Abstract] [Full Text] [Related]
9. [Beta-adrenergic receptor blockers in the treatment of chronic heart failure]. Mularek-Kubzdela T; Grajek S; Cieśliński A Pol Merkur Lekarski; 1996 Aug; 1(2):120-3. PubMed ID: 9156910 [TBL] [Abstract][Full Text] [Related]
10. Treatment of congestive heart failure with beta-adrenergic blockers: a brief review of literature. Lee YC Md Med J; 1998; 47(2):67-71. PubMed ID: 9524413 [TBL] [Abstract][Full Text] [Related]
11. Use of beta-blockers during and after myocardial infarction. Aronow WS Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097 [TBL] [Abstract][Full Text] [Related]
12. [The use of beta-blockers in acute myocardial infarct]. Petrov K Vutr Boles; 1990; 29(3):20-6. PubMed ID: 1980963 [No Abstract] [Full Text] [Related]
13. [Beta-blockers in cardiac insufficiency: should they always be considered in the therapeutic strategy? Arguments against]. Ortigosa Aso J; Silva Melchor L; García A; de Artaza Andrade M Rev Esp Cardiol; 1997 May; 50(5):304-7. PubMed ID: 9281008 [TBL] [Abstract][Full Text] [Related]
14. [Use of beta-blockers in the treatment of chronic heart failure]. Sutka J; Cagán S Vnitr Lek; 1996 Jan; 42(1):37-42. PubMed ID: 8629359 [TBL] [Abstract][Full Text] [Related]
16. Can beta blockers be safely used in patients with recent myocardial infarction who also have congestive heart failure? Julian DG Circulation; 1983 Jun; 67(6 Pt 2):I91. PubMed ID: 6133652 [TBL] [Abstract][Full Text] [Related]
17. Evolving mechanisms of action of beta blockers: focus on nebivolol. Mason RP; Giles TD; Sowers JR J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811 [TBL] [Abstract][Full Text] [Related]
18. [Beta-blocker in secondary prevention of cardiovascular disease]. Sauer G Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298 [TBL] [Abstract][Full Text] [Related]
19. Treating diastolic heart failure: the role of beta-blockers. Cardoso JS Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V97-9. PubMed ID: 10582469 [No Abstract] [Full Text] [Related]
20. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527 [No Abstract] [Full Text] [Related] [Next] [New Search]